FDA
-
-
-
-
-
-
-
Propanc Biopharma targets Feb 2027 for first cancer trial patient
-
-
-
-
-
-
-
Enlivex enrolls 135 patients in knee osteoarthritis Phase 2b trial
-
-
-
-
-
-
-
NovaBridge Biosciences names Chuck Silberstein as CFO
-
-
-
-
-
-
-
TempraMed signs distribution deal for three Southeast European markets
-
-
-
-
-
-
-
Nexalin study finds 15 mA stimulation improves sleep in Alzheimer's
-
-
-
-
-
-
-
Altimmune adds two directors, three to retire ahead of 2027 meeting
-
-
-
-
-
-
-
Neurogene presents NGN-401 gene therapy data at ESGCT congress
-
335,702 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


